| Category | FY | Funding IC | Project Number | Sub Project # | Project Title | PI Name | Org Name | State / Country | Amount |
|
Human Fetal Tissue
|
2017
|
NIAMS
|
4R37AR042455-24
|
|
Maternal Autoantibodies: Pathogenesis of Neonatal Lupus
|
BUYON, JILL
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
NY
|
$366,120
|
|
Human Fetal Tissue
|
2017
|
NIAID
|
5R01AI110297-04
|
|
Hematopoietic stem/progenitor cell reservoirs
|
CHEN, IRVIN
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$385,000
|
|
Human Fetal Tissue
|
2017
|
NIAID
|
5R44AI100401-05
|
|
Broad Spectrum Antiviral Nucleoside Phosphonate Analogs
|
LIPKA, ELKE
|
TSRL, INC.
|
MI
|
$999,700
|
|
Human Fetal Tissue
|
2017
|
NIAID
|
5R21AI122390-02
|
|
Dendritic Cell Vaccine for Controlling the Latent Reservoir
|
LANDAU, NATHANIEL
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
NY
|
$217,685
|
|
Human Fetal Tissue
|
2017
|
NIAMS
|
5R03AR066875-04
|
|
The Mechanical Phenotype of Fetal Fibroblasts as a Model for Regenerative Repair
|
PAREKH, ARON
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
TN
|
$79,000
|
|
Human Fetal Tissue
|
2017
|
NICHD
|
5R03HD083538-02
|
|
Defining interneuron deficits in Down syndrome brain.
|
BHATTACHARYYA, ANITA
|
UNIVERSITY OF WISCONSIN-MADISON
|
WI
|
$80,103
|
|
Human Fetal Tissue
|
2017
|
NIAID
|
5R21AI122384-02
|
|
Exploring antibody-Fc effector function in humanized mouse models of HIV latency
|
KUMAR, PRITI
|
YALE UNIVERSITY
|
CT
|
$243,607
|
|
Human Fetal Tissue
|
2017
|
NIMH
|
5R21MH104775-02
|
|
Connexin Channels in Human Neurons
|
ANTIC, SRDJAN
|
UNIVERSITY OF CONNECTICUT SCH OF MED/DNT
|
CT
|
$195,877
|
|
Human Fetal Tissue
|
2017
|
NIAID
|
5F30AI109830-03
|
|
Therapeutic Applications of Broadly Neutralizing Anti-HIV-1 Antibodies to Clear Latently Infected Cells
|
HALPER-STROMBERG, ARIEL
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
NY
|
$49,044
|
|
Human Fetal Tissue
|
2017
|
NEI
|
5K08EY026101-02
|
|
A nanoparticle platform for targeted delivery of therapeutic agents to retinal pigment epithelial or choroidal endothelial cells
|
YIU, GLENN
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
CA
|
$206,553
|
|
Human Fetal Tissue
|
2017
|
NIMH
|
5R01MH099555-05
|
|
Phenotyping Astrocytes in Human Neurodevelopmental Disorders
|
BARRES, BEN
|
STANFORD UNIVERSITY
|
CA
|
$386,314
|
|
Human Fetal Tissue
|
2017
|
NIDCR
|
5R01DE024188-04
|
|
Neuronal regulation of salivary stem cells
|
KNOX, SARAH
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
CA
|
$396,201
|
|
Human Fetal Tissue
|
2017
|
NIEHS
|
5K99ES025231-02
|
|
Retinoic Acid Signaling Disruption by Phthalates in Human and Rodent Fetal Testis
|
SPADE, DANIEL
|
BROWN UNIVERSITY
|
RI
|
$100,210
|
|
Human Fetal Tissue
|
2017
|
NIMH
|
5R01MH100914-04
|
|
Genomic mosaicism in developing human brain
|
VACCARINO, FLORA
|
YALE UNIVERSITY
|
CT
|
$654,706
|
|
Human Fetal Tissue
|
2017
|
NIAID
|
5U01AI115497-03
|
|
Placental Colonization by Treponema Pallidum, Congenital Syphilis & Novel Vaccine
|
PARVEEN, NIKHAT
|
RBHS-NEW JERSEY MEDICAL SCHOOL
|
NJ
|
$659,423
|
|
Human Fetal Tissue
|
2017
|
NEI
|
5R01EY022936-05
|
|
Humoral Immunity, Astrocyte Injury, and Demyelination in Neuromyelitis Optica
|
BENNETT, JEFFREY
|
UNIVERSITY OF COLORADO DENVER
|
CO
|
$388,750
|
|
Human Fetal Tissue
|
2017
|
NEI
|
5R01EY026030-02
|
|
Human RPE metabolism and metabolite transport
|
CHAO, JENNIFER
|
UNIVERSITY OF WASHINGTON
|
WA
|
$391,500
|
|
Human Fetal Tissue
|
2017
|
NIAID
|
5R01AI029329-27
|
|
Enhancing the Intracellular Functioning of anti-HV RNAS
|
ROSSI, JOHN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
CA
|
$654,174
|
|
Human Fetal Tissue
|
2017
|
NIAID
|
5R01AI116282-03
|
|
Harnessing NK Memory To Protect Against HIV Infection
|
PAUST, SILKE
|
BAYLOR COLLEGE OF MEDICINE
|
TX
|
$558,874
|
|
Human Fetal Tissue
|
2017
|
NIAID
|
5P01AI104715-05
|
5790
|
Optimizing CD8+ T Cell Vaccine Responses Against HIV
|
ALLEN, TODD
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$476,417
|
|
Human Fetal Tissue
|
2017
|
NIAID
|
5P01AI104715-05
|
5798
|
Optimizing Antibody Vaccines Against HIV
|
SCHIEF, WILLIAM
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$735,687
|
|
Human Fetal Tissue
|
2017
|
NIAID
|
5R01AI117740-03
|
|
Long-acting antiretroviral nanoparticles for HIV prophylaxis
|
DESTACHE, CHRISTOPHER
|
CREIGHTON UNIVERSITY
|
NE
|
$543,485
|
|
Human Fetal Tissue
|
2017
|
NIAID
|
5P01AI100148-05
|
7194
|
Human Antibodies to HIV
|
NUSSENZWEIG, MICHEL
|
CALIFORNIA INSTITUTE OF TECHNOLOGY
|
CA
|
$271,200
|
|
Human Fetal Tissue
|
2017
|
NIAID
|
5P01AI100148-05
|
7195
|
Fc effector function in bNAbs
|
RAVETCH, JEFFREY
|
CALIFORNIA INSTITUTE OF TECHNOLOGY
|
CA
|
$508,500
|
|
Human Fetal Tissue
|
2017
|
NIAID
|
5P01AI100148-05
|
7199
|
Animal Services
|
NUSSENZWEIG, MICHEL
|
CALIFORNIA INSTITUTE OF TECHNOLOGY
|
CA
|
$291,684
|
|
Human Fetal Tissue
|
2017
|
NIAID
|
5R01AI117839-03
|
|
Next generation hybrid nucleases for precise excision of latent HIV-1 provirus
|
LUBAN, JEREMY
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
MA
|
$914,295
|
|
Human Fetal Tissue
|
2017
|
NIAID
|
5R01AI112640-03
|
|
Typhoid Pathogenesis and Immunity
|
FANG, FERRIC
|
UNIVERSITY OF WASHINGTON
|
WA
|
$472,348
|
|
Human Fetal Tissue
|
2017
|
NIDCR
|
5R01DE019637-08
|
|
Patterning the vertebrate dentition through replacement and repair
|
STREELMAN, JEFFERY
|
GEORGIA INSTITUTE OF TECHNOLOGY
|
GA
|
$316,376
|
|
Human Fetal Tissue
|
2017
|
NIEHS
|
5K22ES026235-02
|
|
Prenatal biomarkers of exposure and individual susceptibility to endocrine disrupting compounds
|
SNYDER, NATHANIEL
|
DREXEL UNIVERSITY
|
PA
|
$161,730
|
|
Human Fetal Tissue
|
2017
|
NICHD
|
5R01HD075549-04
|
|
INNATE AND ADAPTIVE IMMUNITY TO HCV IN HUMAN PREGNANCY
|
ROSEN, HUGO
|
UNIVERSITY OF COLORADO DENVER
|
CO
|
$321,437
|
|
Human Fetal Tissue
|
2017
|
NICHD
|
5R01HD078561-04
|
|
Development of Brain Connectivity in Human Fetus, Newborn, and Toddler Ages
|
TAKAHASHI, EMI
|
BOSTON CHILDREN'S HOSPITAL
|
MA
|
$322,806
|
|
Human Fetal Tissue
|
2017
|
NIAID
|
5R01AI119012-02
|
|
Lubricant Use and the Vaginal Microbiome
|
BROTMAN, REBECCA
|
UNIVERSITY OF MARYLAND BALTIMORE
|
MD
|
$755,330
|
|
Human Fetal Tissue
|
2017
|
NIAID
|
5R21AI124763-02
|
|
Novel method for evaluating HIV latency and persistence in vivo
|
MARSDEN, MATTHEW
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$231,000
|
|
Human Fetal Tissue
|
2017
|
NIDCR
|
5R01DE023315-05
|
|
Molecular mechanisms of oral HIV transmission modeling MTCT
|
TUGIZOV, SHAROF
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
CA
|
$447,804
|
|
Human Fetal Tissue
|
2017
|
NIAID
|
5R44AI100778-05
|
|
An immune-based approach for HIV eradication
|
LAMA, JUAN
|
RETROVIROX, INC.
|
CA
|
$665,610
|
|
Human Fetal Tissue
|
2017
|
NIAID
|
5R01AI124690-02
|
|
The yellow fever vaccine saga: Defining the viral and host determinants responsible for success versus failure
|
RICE, CHARLES
|
ROCKEFELLER UNIVERSITY
|
NY
|
$798,777
|
|
Human Fetal Tissue
|
2017
|
NIAID
|
5R01AI111891-04
|
|
Multi-Species Mechanisms of Drug Bio-distribution in HIV Tissue Reservoirs
|
KASHUBA, ANGELA
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$728,895
|
|
Human Fetal Tissue
|
2017
|
NIAID
|
5R01AI111899-04
|
|
Plug & Purge: In Vivo Targeting of Active HIV Reservoirs That Persist Despite ART
|
GARCIA-MARTINEZ, J. VICTOR
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$487,499
|
|
Human Fetal Tissue
|
2017
|
NIAID
|
5R01AI119140-02
|
|
Natural vs. Pathogenic Th17 responses to col Va1, Ka1tubulin and vimentin
|
BURLINGHAM, WILLIAM
|
UNIVERSITY OF WISCONSIN-MADISON
|
WI
|
$376,140
|
|
Human Fetal Tissue
|
2017
|
NIAID
|
5R33AI110149-04
|
|
HIV-specific nucleases to reservoir cells
|
CANNON, PAULA
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
CA
|
$495,000
|
|
Human Fetal Tissue
|
2017
|
NIDA
|
5K01DA035298-04
|
|
Prenatal Cigarette Exposure: The Role of Sleep and Parenting for Infant Outcomes
|
PROPPER, CATHI
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$161,849
|
|
Human Fetal Tissue
|
2017
|
NIAID
|
5R01AI123010-02
|
|
The Role of Human Gut Microbiota in HIV-1 Rectal Acquisition, Replication, and Pathogenesis
|
WAHL, ANGELA
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$730,827
|
|
Human Fetal Tissue
|
2017
|
NIMH
|
5K01MH109772-02
|
|
Interpreting GWAS associations in schizophrenia using genome-wide chromatin mapping
|
GIUSTI, PAOLA
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$155,168
|
|
Human Fetal Tissue
|
2017
|
NIAID
|
5R01AI117780-03
|
|
Disruption of latent HIV-1 proviruses using CRISPR/Cas endonucleases
|
CULLEN, BRYAN
|
DUKE UNIVERSITY
|
NC
|
$735,615
|
|
Human Fetal Tissue
|
2017
|
NIDDK
|
5R01DK103585-03
|
|
Immune Response to iPSC-Derived Beta Cells in Type 1 Diabetes
|
SYKES, MEGAN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
NY
|
$455,801
|
|
Human Fetal Tissue
|
2017
|
NEI
|
5R01EY026661-02
|
|
Human Specific Signaling Circuitry in Cone Precursor Development
|
COBRINIK, DAVID
|
CHILDREN'S HOSPITAL OF LOS ANGELES
|
CA
|
$416,250
|
|
Human Fetal Tissue
|
2017
|
NIAMS
|
1R01AR069582-01A1
|
|
Tetraspanin CD82 in muscle satellite cells quiescence and differentiation
|
GUSSONI, EMANUELA
|
BOSTON CHILDREN'S HOSPITAL
|
MA
|
$384,093
|
|
Human Fetal Tissue
|
2017
|
NIAID
|
5R01AI111809-04
|
|
Boosting cell-intrinsic innate immune recognition of HIV-1 by dendritic cells
|
LUBAN, JEREMY
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
MA
|
$586,375
|
|
Human Fetal Tissue
|
2017
|
NEI
|
2R01EY017011-12
|
|
Endothelial Transmigration in Neovascular Age-related Macular Degeneration
|
HARTNETT, MARY ELIZABETH
|
UNIVERSITY OF UTAH
|
UT
|
$378,438
|
|
Human Fetal Tissue
|
2017
|
NEI
|
5R01EY026682-02
|
|
Mechanistic Studies on Regenerative Medicine Approaches to Childhood Blindness
|
BASSUK, ALEXANDER
|
UNIVERSITY OF IOWA
|
IA
|
$389,825
|
|
Human Fetal Tissue
|
2017
|
NEI
|
5R01EY012042-16
|
|
RPE Lactate Transporters: A Role in Retinal Survival
|
PHILP, NANCY
|
THOMAS JEFFERSON UNIVERSITY
|
PA
|
$501,173
|
|
Human Fetal Tissue
|
2017
|
NHGRI
|
1UM1HG009444-01
|
|
ENCODE Mapping Center-A Comprehensive Catalog of DNase I Hypersensitive Sites
|
STAMATOYANNOPOULOS, JOHN
|
ALTIUS INSTITUTE FOR BIOMEDICAL SCIENCES
|
WA
|
$3,086,945
|
|
Human Fetal Tissue
|
2017
|
NEI
|
5K08EY026652-02
|
|
Identification of the genetic pathways that give rise to the chicken rod-free zone and human fovea using epigenomic profiling
|
HAFLER, BRIAN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$276,928
|
|
Human Fetal Tissue
|
2017
|
NIDCR
|
5R00DE024194-05
|
|
Identification of human orofacial enhancers and their role in orofacial clefts
|
COTNEY, JUSTIN
|
UNIVERSITY OF CONNECTICUT SCH OF MED/DNT
|
CT
|
$239,279
|
|
Human Fetal Tissue
|
2017
|
NIAID
|
5U19AI117941-03
|
5328
|
Improve the engraftment of combinatorial anti-HIV-1 gene modified HSPC
|
AN, DONG SUNG
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$384,429
|
|
Human Fetal Tissue
|
2017
|
NIAID
|
5U19AI117941-03
|
5329
|
Tracking the clonal behavior of repopulating cells
|
CHEN, IRVIN
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$488,723
|
|
Human Fetal Tissue
|
2017
|
NIAID
|
5U19AI117941-03
|
5330
|
Characterization of CAR-directed T-cells to suppress HIV-1 in vivo
|
KITCHEN, SCOTT
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$676,680
|
|
Human Fetal Tissue
|
2017
|
NIAID
|
5U19AI117941-03
|
5331
|
Pre-clinical development of gene modified stem cells and CAR T-cells for HIV-1
|
SYMONDS, GEOFFREY
|
CALIMMUNE, INC.
|
AZ
|
$241,842
|
|
Human Fetal Tissue
|
2017
|
NIAID
|
5R01AI111860-04
|
|
T-cell-mediated targeting of therapeutics to HIV reservoirs
|
IRVINE, DARRELL
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
MA
|
$422,887
|
|
Human Fetal Tissue
|
2017
|
NIMH
|
5R00MH102357-04
|
|
Genetic Influences on Human Cortical Development
|
STEIN, JASON
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$249,000
|
|
Human Fetal Tissue
|
2017
|
NIAID
|
5U01AI124297-02
|
|
Combination Adjuvants to Activate Human Dendritic Cell Subsets and B Cells
|
BANCHEREAU, JACQUES
|
JACKSON LABORATORY
|
ME
|
$640,154
|
|
Human Fetal Tissue
|
2017
|
NIAID
|
5R01AI111862-04
|
|
Improve the safety of an efficacious live-attenuated HIV-1 vaccine through unnatu
|
GUO, JIANTAO
|
UNIVERSITY OF NEBRASKA LINCOLN
|
NE
|
$484,455
|
|
Human Fetal Tissue
|
2017
|
NINDS
|
5R01NS069605-07
|
|
A Genomic Approach to Epilepsy
|
MEFFORD, HEATHER
|
UNIVERSITY OF WASHINGTON
|
WA
|
$607,664
|
|
Human Fetal Tissue
|
2017
|
NIAID
|
5R01AI057083-12
|
|
Small Molecule Inhibitors of HIV Nef Signaling
|
SMITHGALL, THOMAS
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$385,000
|
|
Human Fetal Tissue
|
2017
|
NIDCR
|
5U01DE024427-04
|
|
Genomic, Transgenic and Knockout Resources for Craniofacial Enhancer Studies
|
VISEL, AXEL
|
UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB
|
CA
|
$638,909
|
|
Human Fetal Tissue
|
2017
|
NICHD
|
5R01HD058047-09
|
|
Understanding epigenetic remodeling in primordial germ cells
|
CLARK, AMANDER
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$319,550
|
|
Human Fetal Tissue
|
2017
|
NIMH
|
5R00MH101252-04
|
|
Foxp2 regulation of sex specific transcriptional pathways and brain development
|
BOWERS, JERALD
|
VIRGINIA POLYTECHNIC INST AND ST UNIV
|
VA
|
$243,548
|
|
Human Fetal Tissue
|
2017
|
NIDDK
|
1R21DK111216-01A1
|
|
Smooth Muscle Cell-Based Assesment and Therapy for Myopathic forms of CIPO
|
MARTIN, MARTIN
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$231,150
|
|
Human Fetal Tissue
|
2017
|
NIAID
|
5R01AI111789-04
|
|
Harnessing type 1 IFN-stimulated antiviral mechanisms for HIV vaccine design
|
HAHN, BEATRICE
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$198,368
|
|
Human Fetal Tissue
|
2017
|
NEI
|
5R01EY014685-15
|
|
Molecular Genetics of high Myopia
|
YOUNG, TERRI
|
UNIVERSITY OF WISCONSIN-MADISON
|
WI
|
$600,980
|
|
Human Fetal Tissue
|
2017
|
NIAID
|
5F30AI112487-04
|
|
Investigating graft-versus-host clearance of HIV-infected cells in vivo
|
TSAI, PERRY
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$40,878
|
|
Human Fetal Tissue
|
2017
|
NIDDK
|
5F32DK109616-02
|
|
Characterization of in vivo and in vitro nephrogenesis
|
KIM, ALBERT
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
CA
|
$57,066
|
|
Human Fetal Tissue
|
2017
|
NIAID
|
5R01AI118500-03
|
|
Engineering T-cells with optimized anti-HIV chimeric antigen receptors and CCR5 disruption as a strategy to target HIV-infected cells
|
WAGNER, THOR
|
SEATTLE CHILDREN'S HOSPITAL
|
WA
|
$488,955
|
|
Human Fetal Tissue
|
2017
|
NIAID
|
5R01AI120021-03
|
|
An Ultrasensitive In Vivo Latent HIV Viral Outgrowth Assay Using Humanized Mice
|
AKKINA, RAMESH
|
COLORADO STATE UNIVERSITY
|
CO
|
$683,227
|
|
Human Fetal Tissue
|
2017
|
NIBIB
|
5R44EB019239-03
|
|
Tracking cardiac engraftment and viability of MiPSC by MRI
|
BELL, CALEB
|
BELL BIOSYSTEMS, INC.
|
CA
|
$479,285
|
|
Human Fetal Tissue
|
2017
|
NIDDK
|
5R01DK100664-05
|
|
Hepatic Non-viral Gene Therapy
|
HUANG, LEAF
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$330,600
|
|
Human Fetal Tissue
|
2017
|
NINDS
|
5R01NS050375-13
|
|
The genetic basis of Dandy-Walker and other mid-hindbrain malformations
|
DOBYNS, WILLIAM
|
SEATTLE CHILDREN'S HOSPITAL
|
WA
|
$789,499
|
|
Human Fetal Tissue
|
2017
|
NIAID
|
5R01AI127142-02
|
|
Macrophage Ontogeny and Polarization in HIV/SIV Infection
|
CLEMENTS, JANICE
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$766,282
|
|
Human Fetal Tissue
|
2017
|
NIAID
|
5R01AI127346-02
|
|
HIV-1 Vpr disrupts the IFN-TET-ISG pathway to promote HIV-1 infection and persistence
|
SU, LISHAN
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$532,000
|
|
Human Fetal Tissue
|
2017
|
NIAID
|
5R01AI124843-02
|
|
Development of SMAC mimetics as latency-reversing agents
|
CHANDA, SUMIT
|
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
|
CA
|
$663,969
|
|
Human Fetal Tissue
|
2017
|
NIAID
|
5R01AI124743-02
|
|
HIV latency reversal through novel, potent PKC modulators
|
ZACK, JEROME
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$628,963
|
|
Human Fetal Tissue
|
2017
|
NIAID
|
5R21AI126419-02
|
|
Transformational platform for regenerating autologous transplantable endocrine tissue from human pancreatic matrix and pluripotent stem cells
|
ODORICO, JON
|
UNIVERSITY OF WISCONSIN-MADISON
|
WI
|
$184,890
|
|
Human Fetal Tissue
|
2017
|
NIAID
|
5U19AI109784-04
|
8866
|
Modeling DENV Infection and PRINT-NP Based DENV Vaccines in Humanized Mice
|
TING, JENNY
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$431,411
|
|
Human Fetal Tissue
|
2017
|
NINDS
|
5P01NS083513-04
|
|
Regulation of Cellular Pathwaysin Human Brain Development
|
ROWITCH, DAVID
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
CA
|
$995,658
|
|
Human Fetal Tissue
|
2017
|
NINDS
|
5R21NS093145-02
|
|
Developing Novel Therapeutic Approaches for White Matter Injury in the Neonatal Brain
|
DENEEN, BENJAMIN
|
BAYLOR COLLEGE OF MEDICINE
|
TX
|
$237,750
|
|
Human Fetal Tissue
|
2017
|
NEI
|
2R01EY016151-11
|
|
Inflammatory cells of choroid: a therapeutic target in AMD.
|
LUTTY, GERARD
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$509,566
|
|
Human Fetal Tissue
|
2017
|
NINDS
|
5R21NS098091-02
|
|
Stem Cell Generation of Transport Epithelia for the Brain's Ventricular System
|
CONOVER, JOANNE
|
UNIVERSITY OF CONNECTICUT STORRS
|
CT
|
$192,406
|
|
Human Fetal Tissue
|
2017
|
NIAID
|
5K23AI110731-04
|
|
Age related Differences in Chronic Rhinosinusitis and Nasal Polyps
|
CHO, SEONG
|
UNIVERSITY OF SOUTH FLORIDA
|
FL
|
$142,138
|
|
Human Fetal Tissue
|
2017
|
NIAID
|
5UM1AI126620-02
|
|
BEAT-HIV: Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy
|
MONTANER, LUIS
|
WISTAR INSTITUTE
|
PA
|
$4,242,437
|
|
Human Fetal Tissue
|
2017
|
NIDA
|
5UM1AI126620-02
|
|
BEAT-HIV: Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy
|
MONTANER, LUIS
|
WISTAR INSTITUTE
|
PA
|
$231,069
|
|
Human Fetal Tissue
|
2017
|
NINDS
|
5UM1AI126620-02
|
|
BEAT-HIV: Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy
|
MONTANER, LUIS
|
WISTAR INSTITUTE
|
PA
|
$115,529
|
|
Human Fetal Tissue
|
2017
|
NIAID
|
5UM1AI126619-02
|
|
Collaboratory of AIDS Researchers for Eradication (CARE)
|
MARGOLIS, DAVID
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$4,246,046
|
|
Human Fetal Tissue
|
2017
|
NIDA
|
5UM1AI126619-02
|
|
Collaboratory of AIDS Researchers for Eradication (CARE)
|
MARGOLIS, DAVID
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$231,268
|
|
Human Fetal Tissue
|
2017
|
NINDS
|
5UM1AI126619-02
|
|
Collaboratory of AIDS Researchers for Eradication (CARE)
|
MARGOLIS, DAVID
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$115,636
|
|
Human Fetal Tissue
|
2017
|
NIDDK
|
5R01DK107286-02
|
|
Signaling Pathways in MDS
|
SAKAMOTO, KATHLEEN
|
STANFORD UNIVERSITY
|
CA
|
$350,691
|
|
Human Fetal Tissue
|
2017
|
NIAID
|
5U19AI113048-04
|
6465
|
Project 1: Pharmacokinetics of Combination Antiretroviral Intravaginal Rings
|
HENDRIX, CRAIG
|
OAK CREST INSTITUTE OF SCIENCE
|
CA
|
$875,428
|
|
Human Fetal Tissue
|
2017
|
NIAID
|
5U19AI113048-04
|
6466
|
Project 2: Safety Evaluation of Combination Antiretroviral Intravaginal Rings
|
BAUM, MARC
|
OAK CREST INSTITUTE OF SCIENCE
|
CA
|
$508,039
|
|
Human Fetal Tissue
|
2017
|
NIAID
|
5U19AI113048-04
|
6467
|
Project 3: Anti-HIV/SHIV Efficacy of Combination Antiretroviral Intravaginal Ring
|
PYLES, RICHARD
|
OAK CREST INSTITUTE OF SCIENCE
|
CA
|
$810,708
|
|
Human Fetal Tissue
|
2017
|
NIAID
|
5R01AI042552-20
|
|
Combinatorial Use of Anti-HIV RNA-based Therapeutics
|
ROSSI, JOHN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
CA
|
$512,462
|
|
Human Fetal Tissue
|
2017
|
NIAID
|
5R01AI110200-02
|
|
Gene-engineered stem cell memory T-cells with anti-HIV chimeric antigen receptors
|
KAMATA, MASAKAZU
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$385,000
|
|
Human Fetal Tissue
|
2017
|
NIEHS
|
5P01ES022841-05
|
7880
|
Project 2: Mid-Gestational Exposure to EDCs and Effects on Placental Developmen
|
WOODRUFF, TRACEY
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
CA
|
$140,891
|
|
Human Fetal Tissue
|
2017
|
NIMH
|
5R01MH096625-08
|
|
Astrocyte connexin43 containing channels amplify CNS dysfunction in NeuroAIDS
|
EUGENIN, ELISEO
|
RBHS-NEW JERSEY MEDICAL SCHOOL
|
NJ
|
$479,536
|
|
Human Fetal Tissue
|
2017
|
NIAID
|
5R01AI123234-02
|
|
Modeling the molecular evolution of SIV to HIV using humanized mice
|
AKKINA, RAMESH
|
COLORADO STATE UNIVERSITY
|
CO
|
$477,633
|
|
Human Fetal Tissue
|
2017
|
NIAAA
|
5R01AA025215-02
|
|
The roles of alcohol-inducible RNA-operons in the fetal brain
|
HASHIMOTO-TORII, KAZUE
|
CHILDREN'S RESEARCH INSTITUTE
|
DC
|
$374,444
|
|
Human Fetal Tissue
|
2017
|
NEI
|
5K99EY027013-02
|
|
Defining oxidative stress induced changes in RPE that control RPE and photoreceptor degeneration
|
BISWAL, MANAS
|
UNIVERSITY OF FLORIDA
|
FL
|
$128,817
|
|
Human Fetal Tissue
|
2017
|
NIAID
|
1P01AI131294-01
|
7200
|
Mouse Core
|
KITCHEN, SCOTT
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$154,001
|
|
Human Fetal Tissue
|
2017
|
NIAID
|
1P01AI131294-01
|
7201
|
Defining the causes and consequences of viral rebound
|
MARSDEN, MATTHEW
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$354,198
|
|
Human Fetal Tissue
|
2017
|
NIAID
|
1P01AI131294-01
|
7202
|
Impact of engineered immune cells on viral rebound
|
ZACK, JEROME
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$354,200
|
|
Human Fetal Tissue
|
2017
|
NIAID
|
1P01AI131294-01
|
7203
|
Effects of Vaccine on Formation and Clearance of the HIV Latent Reservoir
|
YANG, OTTO
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$354,199
|
|
Human Fetal Tissue
|
2017
|
NIAID
|
5R33AI116205-04
|
|
Targeting latent HIV-1 Reservoirs with the Antibody-Drug Conjugate, Brentuximab Vedotin
|
HENRICH, TIMOTHY
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
CA
|
$403,568
|
|
Human Fetal Tissue
|
2017
|
NIAID
|
5R01AI124804-02
|
|
Impact of Fc N-glycan structure on HIV-specific antibody functions
|
JARVIS, DONALD
|
UNIVERSITY OF WYOMING
|
WY
|
$428,340
|
|
Human Fetal Tissue
|
2017
|
NIGMS
|
5R01AI124804-02
|
|
Impact of Fc N-glycan structure on HIV-specific antibody functions
|
JARVIS, DONALD
|
UNIVERSITY OF WYOMING
|
WY
|
$320,000
|
|
Human Fetal Tissue
|
2017
|
NHLBI
|
5UM1HL098147-09
|
|
The Genomic Basis of Congenital Heart Disease and Neurodevelopmental Outcomes
|
NEWBURGER, JANE
|
BOSTON CHILDREN'S HOSPITAL
|
MA
|
$441,803
|
|
Human Fetal Tissue
|
2017
|
NICHD
|
5UM1HL098147-09
|
|
The Genomic Basis of Congenital Heart Disease and Neurodevelopmental Outcomes
|
NEWBURGER, JANE
|
BOSTON CHILDREN'S HOSPITAL
|
MA
|
$35,000
|
|
Human Fetal Tissue
|
2017
|
NIAID
|
5K22AI118421-02
|
|
Development of Immune-Modulated HIV Vaccines
|
PENALOZA, PABLO
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
IL
|
$108,000
|
|
Human Fetal Tissue
|
2017
|
NEI
|
5R01EY023853-02
|
|
Nanogels for Drug Delivery across the BRB to Treat Diabetic Retinopathy
|
LOWE, TAO
|
UNIVERSITY OF TENNESSEE HEALTH SCI CTR
|
TN
|
$380,000
|
|
Human Fetal Tissue
|
2017
|
NIAID
|
1U01AI131566-01
|
|
Determining how macrophages regulate immunity to Zika virus infection at the maternal-fetal interface
|
CHAKRABORTY, RANA
|
EMORY UNIVERSITY
|
GA
|
$213,520
|
|
Human Fetal Tissue
|
2017
|
OD
|
1U01AI131566-01
|
|
Determining how macrophages regulate immunity to Zika virus infection at the maternal-fetal interface
|
CHAKRABORTY, RANA
|
EMORY UNIVERSITY
|
GA
|
$250,000
|
|
Human Fetal Tissue
|
2017
|
NINDS
|
5R01NS095733-02
|
|
Pathological Mechanisms of Human Cerebeller Malformations
|
MILLEN, KATHLEEN
|
SEATTLE CHILDREN'S HOSPITAL
|
WA
|
$578,074
|
|
Human Fetal Tissue
|
2017
|
NEI
|
5R01EY025667-03
|
|
High-throughput bioengineering technologies for vision restoration
|
CHAVALA, SAI
|
UNIVERSITY OF NORTH TEXAS HLTH SCI CTR
|
TX
|
$365,000
|
|
Human Fetal Tissue
|
2017
|
NEI
|
5R01EY008538-27
|
|
RETINA: REVERSED POLARITY AND MORPHOGENESIS OF RPE
|
RODRIGUEZ-BOULAN, ENRIQUE
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
NY
|
$515,892
|
|
Human Fetal Tissue
|
2017
|
NEI
|
5R01EY008850-25
|
|
Ion conductances in the retinal pigment epithelium
|
HUGHES, BRET
|
UNIVERSITY OF MICHIGAN
|
MI
|
$387,500
|
|
Human Fetal Tissue
|
2017
|
NIMH
|
5R01MH107340-02
|
|
PINCH-mediated CNS cell dysfunction and tauopathy in HIV
|
LANGFORD, TERESA
|
TEMPLE UNIV OF THE COMMONWEALTH
|
PA
|
$415,020
|
|
Human Fetal Tissue
|
2017
|
FIC
|
1G11TW010553-01
|
|
CAPRISA Research Administration and Management Training Program
|
BAXTER, CHERYL
|
CENTRE/AIDS PROGRAMME/RES/SOUTH AFRICA
|
SO AFR
|
$99,360
|
|
Human Fetal Tissue
|
2017
|
FIC
|
1D43TW010562-01
|
|
Ukraine HIV Research Training Program
|
DEHOVITZ, JACK
|
SUNY DOWNSTATE MEDICAL CENTER
|
NY
|
$202,483
|
|
Human Fetal Tissue
|
2017
|
NIDA
|
1D43TW010562-01
|
|
Ukraine HIV Research Training Program
|
DEHOVITZ, JACK
|
SUNY DOWNSTATE MEDICAL CENTER
|
NY
|
$100,000
|
|
Human Fetal Tissue
|
2017
|
FIC
|
1G11TW010348-01A1
|
|
Enhancing HIV Research Training Capacity in University of Rwanda's Research Office
|
ADEDIMEJI, ADEBOLA
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
NY
|
$99,605
|
|
Human Fetal Tissue
|
2017
|
NINDS
|
5R21NS096413-02
|
|
Novel gene editing strategy for eliminating human neurotropic JCV in glial cells
|
WOLLEBO, HASSEN
|
TEMPLE UNIV OF THE COMMONWEALTH
|
PA
|
$195,000
|
|
Human Fetal Tissue
|
2017
|
NIDDK
|
5R01DK100854-04
|
|
Modeling genetic modifiers of hematopoiesis with induced pluripotent stem cells
|
CHOU, STELLA
|
CHILDREN'S HOSP OF PHILADELPHIA
|
PA
|
$365,400
|
|
Human Fetal Tissue
|
2017
|
NICHD
|
5R37HD021341-33
|
|
A Program of Research in Population Cytogenetics
|
HASSOLD, TERRY
|
WASHINGTON STATE UNIVERSITY
|
WA
|
$601,001
|
|
Human Fetal Tissue
|
2017
|
NINDS
|
1R01NS104015-01
|
|
Nanopeptide Targeting of HIV-CNS Reservoirs without Reactivation
|
SPECTOR, STEPHEN
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$494,678
|
|
Human Fetal Tissue
|
2017
|
NIDDK
|
5U01DK110812-02
|
|
GUDMAP: Mapping molecular regionalization of cell types along the anterior-posterior axis of the urethra
|
COHN, MARTIN
|
UNIVERSITY OF FLORIDA
|
FL
|
$493,916
|
|
Human Fetal Tissue
|
2017
|
NIDDK
|
5U01DK110792-02
|
|
Four-dimensional Modeling of Mouse and Human Nephrogenesis.
|
MCMAHON, ANDREW
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
CA
|
$387,083
|
|
Human Fetal Tissue
|
2017
|
NIDDK
|
5U01DK110803-02
|
|
GENERATING AN ATLAS OF THE DEVELOPING HUMAN URINARY OUTFLOW TRACT.
|
MENDELSOHN, CATHY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
NY
|
$319,000
|
|
Human Fetal Tissue
|
2017
|
NIDDK
|
5U01DK110807-02
|
|
Molecular and fate maps of prostatic stroma
|
VEZINA, CHAD
|
UNIVERSITY OF WISCONSIN-MADISON
|
WI
|
$297,919
|
|
Human Fetal Tissue
|
2017
|
NIDDK
|
5U24DK110791-02
|
|
University of Pittsburgh as the GUDMAP Tissue Hub and Collection Site
|
DHIR, RAJIV
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$479,336
|
|
Human Fetal Tissue
|
2017
|
NIMH
|
5R00MH102352-04
|
|
Variation in serotonin 1a receptor expression as a source of depression risk
|
DONALDSON, ZOE
|
UNIVERSITY OF COLORADO
|
CO
|
$307,633
|
|
Human Fetal Tissue
|
2017
|
NIMH
|
5R21MH109385-02
|
|
Role of Exosomes in the Crosstalk Between Brain Endothelium and HIV Neuroinvasion
|
LI, JIELIANG
|
TEMPLE UNIV OF THE COMMONWEALTH
|
PA
|
$195,000
|
|
Human Fetal Tissue
|
2017
|
NINDS
|
5R21NS100477-02
|
|
Host-pathogen interactions in ZIKV infection leading to microcephaly
|
STRONGIN, ALEX
|
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
|
CA
|
$236,250
|
|
Human Fetal Tissue
|
2017
|
NINDS
|
5R01NS097195-02
|
|
Glutaminase and its neurotoxic link to HAND
|
ZHENG, JIALIN
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
NE
|
$376,250
|
|
Human Fetal Tissue
|
2017
|
NIAID
|
2P01AI045897-17
|
5703
|
Tolerance of Adaptive and Innate Human Anti-pig Immune Responses in Humanized Mice
|
SYKES, MEGAN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
NY
|
$453,298
|
|
Human Fetal Tissue
|
2017
|
NEI
|
5R01EY026492-02
|
|
Defining the role of immune-neuronal crosstalk in dry eye disease
|
KNOX, SARAH
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
CA
|
$396,250
|
|
Human Fetal Tissue
|
2017
|
NIAID
|
1R01AI132963-01
|
|
Novel humanized mouse model developed from cord blood CD34 positive HSC and autologous iPS cell derived thymus
|
BREHM, MICHAEL
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
MA
|
$799,559
|
|
Human Fetal Tissue
|
2017
|
NIAID
|
5F32AI125096-02
|
|
The Use of Monoclonal Antibodies Delivered by Viral Vector as an HIV-1 Therapeutic
|
DEAL, CAILIN
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$59,166
|
|
Human Fetal Tissue
|
2017
|
NIAID
|
1R03AI128254-01A1
|
|
Anti-osteogenic functions of lipocalin2, an innate immune protein, during autoimmune arthritis
|
SHASHIDHARAMURTHY, RANGAIAH
|
PHILADELPHIA COLLEGE OF OSTEOPATHIC MED
|
PA
|
$83,950
|
|
Human Fetal Tissue
|
2017
|
NIDDK
|
3F32DK109616-01S1
|
|
Characterization of in vivo and in vitro nephrogenesis
|
KIM, ALBERT
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
CA
|
$1,800
|
|
Human Fetal Tissue
|
2017
|
NINDS
|
1F32NS103266-01
|
|
Using Single-Cell RNA Sequencing to Characterize Regional Differences in Cortical Development
|
BHADURI, APARNA
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
CA
|
$56,694
|
|
Human Fetal Tissue
|
2017
|
FIC
|
1U54CA221204-01
|
6386
|
Administrative Core
|
WOOD, CHARLES
|
UNIVERSITY OF NEBRASKA LINCOLN
|
NE
|
$23,134
|
|
Human Fetal Tissue
|
2017
|
NCI
|
1U54CA221204-01
|
6386
|
Administrative Core
|
WOOD, CHARLES
|
UNIVERSITY OF NEBRASKA LINCOLN
|
NE
|
$155,060
|
|
Human Fetal Tissue
|
2017
|
FIC
|
1U54CA221204-01
|
6387
|
Biostatistics/Epidemiology Core
|
HAYNATZKI, GLEB
|
UNIVERSITY OF NEBRASKA LINCOLN
|
NE
|
$7,005
|
|
Human Fetal Tissue
|
2017
|
NCI
|
1U54CA221204-01
|
6387
|
Biostatistics/Epidemiology Core
|
HAYNATZKI, GLEB
|
UNIVERSITY OF NEBRASKA LINCOLN
|
NE
|
$46,954
|
|
Human Fetal Tissue
|
2017
|
FIC
|
1U54CA221204-01
|
6388
|
Laboratory Core
|
WEST, JOHN
|
UNIVERSITY OF NEBRASKA LINCOLN
|
NE
|
$24,033
|
|
Human Fetal Tissue
|
2017
|
NCI
|
1U54CA221204-01
|
6388
|
Laboratory Core
|
WEST, JOHN
|
UNIVERSITY OF NEBRASKA LINCOLN
|
NE
|
$161,088
|
|
Human Fetal Tissue
|
2017
|
FIC
|
1U54CA221204-01
|
6389
|
Research Project 1: Epidemiology of Kaposi's Sarcoma and Kaposi's Sarcoma-Associated Herpesvirus
|
NGALAMIKA, OWEN
|
UNIVERSITY OF NEBRASKA LINCOLN
|
NE
|
$14,270
|
|
Human Fetal Tissue
|
2017
|
NCI
|
1U54CA221204-01
|
6389
|
Research Project 1: Epidemiology of Kaposi's Sarcoma and Kaposi's Sarcoma-Associated Herpesvirus
|
NGALAMIKA, OWEN
|
UNIVERSITY OF NEBRASKA LINCOLN
|
NE
|
$95,648
|
|
Human Fetal Tissue
|
2017
|
FIC
|
1U54CA221204-01
|
6390
|
Research Project 2: Pathological Diagnosis and Etiology of Ocular Surface Squamous Neoplasia in Zambia
|
ANGELETTI, PETER
|
UNIVERSITY OF NEBRASKA LINCOLN
|
NE
|
$13,614
|
|
Human Fetal Tissue
|
2017
|
NCI
|
1U54CA221204-01
|
6390
|
Research Project 2: Pathological Diagnosis and Etiology of Ocular Surface Squamous Neoplasia in Zambia
|
ANGELETTI, PETER
|
UNIVERSITY OF NEBRASKA LINCOLN
|
NE
|
$91,254
|
|
Human Fetal Tissue
|
2017
|
FIC
|
1U54CA221204-01
|
6391
|
Career Enhancement Core
|
WOOD, CHARLES
|
UNIVERSITY OF NEBRASKA LINCOLN
|
NE
|
$17,944
|
|
Human Fetal Tissue
|
2017
|
NCI
|
1U54CA221204-01
|
6391
|
Career Enhancement Core
|
WOOD, CHARLES
|
UNIVERSITY OF NEBRASKA LINCOLN
|
NE
|
$120,276
|
|
Human Fetal Tissue
|
2017
|
FIC
|
1U54CA221205-01
|
6392
|
Administrative Core
|
HOU, LIFANG
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
IL
|
$10,077
|
|
Human Fetal Tissue
|
2017
|
NCI
|
1U54CA221205-01
|
6392
|
Administrative Core
|
HOU, LIFANG
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
IL
|
$74,100
|
|
Human Fetal Tissue
|
2017
|
FIC
|
1U54CA221205-01
|
6393
|
Pathology and Genomics Core
|
WEI, JIAN-JUN
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
IL
|
$11,865
|
|
Human Fetal Tissue
|
2017
|
NCI
|
1U54CA221205-01
|
6393
|
Pathology and Genomics Core
|
WEI, JIAN-JUN
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
IL
|
$87,251
|
|
Human Fetal Tissue
|
2017
|
FIC
|
1U54CA221205-01
|
6394
|
Biomedical Informatics and Statistics Core
|
LIU, LEI
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
IL
|
$20,401
|
|
Human Fetal Tissue
|
2017
|
NCI
|
1U54CA221205-01
|
6394
|
Biomedical Informatics and Statistics Core
|
LIU, LEI
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
IL
|
$150,024
|
|
Human Fetal Tissue
|
2017
|
FIC
|
1U54CA221205-01
|
6395
|
Epigenetic Biomarkers of HIV-Associated Hepatocellular Carcinoma in Nigeria
|
ROBERTS, LEWIS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
IL
|
$29,604
|
|
Human Fetal Tissue
|
2017
|
NCI
|
1U54CA221205-01
|
6395
|
Epigenetic Biomarkers of HIV-Associated Hepatocellular Carcinoma in Nigeria
|
ROBERTS, LEWIS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
IL
|
$217,703
|
|
Human Fetal Tissue
|
2017
|
FIC
|
1U54CA221205-01
|
6396
|
Epigenetic Biomarkers of HIV-Associated Cervical Cancer in Nigeria
|
SIMON, MELISSA
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
IL
|
$15,056
|
|
Human Fetal Tissue
|
2017
|
NCI
|
1U54CA221205-01
|
6396
|
Epigenetic Biomarkers of HIV-Associated Cervical Cancer in Nigeria
|
SIMON, MELISSA
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
IL
|
$110,720
|
|
Human Fetal Tissue
|
2017
|
FIC
|
1U54CA221205-01
|
6397
|
Career Enhancement Core
|
MURPHY, ROBERT
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
IL
|
$12,997
|
|
Human Fetal Tissue
|
2017
|
NCI
|
1U54CA221205-01
|
6397
|
Career Enhancement Core
|
MURPHY, ROBERT
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
IL
|
$95,575
|
|
Human Fetal Tissue
|
2017
|
NIAID
|
1R01AI131975-01A1
|
|
Directing Antibody Effector Activity via Controlled IgG Subclass Switching
|
ACKERMAN, MARGARET
|
DARTMOUTH COLLEGE
|
NH
|
$300,814
|
|
Human Fetal Tissue
|
2017
|
NIGMS
|
1R01AI131975-01A1
|
|
Directing Antibody Effector Activity via Controlled IgG Subclass Switching
|
ACKERMAN, MARGARET
|
DARTMOUTH COLLEGE
|
NH
|
$320,000
|
|
Human Fetal Tissue
|
2017
|
NICHD
|
2R24HD000836-52
|
|
Laboratory of Developmental Biology
|
GLASS, IAN
|
UNIVERSITY OF WASHINGTON
|
WA
|
$834,581
|
|
Human Fetal Tissue
|
2017
|
NIAAA
|
3R01AA025215-02S1
|
|
The roles of alcohol-inducible RNA-operons in the fetal brain
|
HASHIMOTO-TORII, KAZUE
|
CHILDREN'S RESEARCH INSTITUTE
|
DC
|
$108,539
|
|
Human Fetal Tissue
|
2017
|
NIDDK
|
3U01DK110807-02S1
|
|
Molecular and fate maps of prostatic stroma
|
VEZINA, CHAD
|
UNIVERSITY OF WISCONSIN-MADISON
|
WI
|
$65,741
|
|
Human Fetal Tissue
|
2017
|
NICHD
|
3R24HD000836-51S1
|
|
LABORATORY OF DEVELOPMENTAL BIOLOGY
|
GLASS, IAN
|
UNIVERSITY OF WASHINGTON
|
WA
|
$160,699
|
|
Human Fetal Tissue
|
2017
|
NIMH
|
271201300028C-9-0-1
|
|
NIMH, NICHD, AND NINDS BRAIN AND TISSUE REPOSITORY
|
MASH, DEBORAH
|
NIH
|
|
$874,304
|
|
Human Fetal Tissue
|
2017
|
NINDS
|
271201300028C-9-0-2
|
|
IGF::OT::IGF
|
MASH, DEBORAH
|
NIH
|
|
$463,155
|
|
Human Fetal Tissue
|
2017
|
NIDDK
|
2R56DK100959-04
|
|
Defining the Self-Renewal Program in Human Hematopoietic Stem Cells
|
MIKKOLA, HANNA
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$226,470
|
|
Human Fetal Tissue
|
2017
|
NEI
|
3R01EY017011-12S1
|
|
Endothelial Transmigration in Neovascular Age-related Macular Degeneration
|
HARTNETT, MARY ELIZABETH
|
UNIVERSITY OF UTAH
|
UT
|
$66,016
|
|
Human Fetal Tissue
|
2017
|
NIMH
|
271201300029C-6-0-1
|
|
NIMH, NICHD, AND NINDS BRAIN AND TISSUE REPOSITORY
|
NAGRA, RASHED
|
SEPULVEDA RESEARCH CORPORATION
|
CA
|
$744,764
|
|
Human Fetal Tissue
|
2017
|
NINDS
|
271201300029C-6-0-2
|
|
IGF::OT::IGF
|
NAGRA, RASHED
|
SEPULVEDA RESEARCH CORPORATION
|
CA
|
$443,646
|
|
Human Fetal Tissue
|
2017
|
NIMH
|
271201300032C-6-0-1
|
|
NIMH, NICHD, AND NINDS BRAIN AND TISSUE REPOSITORY
|
LEWIS, DAVID
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$1,390,519
|
|
Human Fetal Tissue
|
2017
|
NIMH
|
271201300031C-7-0-1
|
|
NIMH, NICHD, AND NINDS BRAIN AND TISSUE REPOSITORY
|
HAROUTUNIAN, VAHRAM
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
NY
|
$633,198
|
|
Human Fetal Tissue
|
2017
|
NINDS
|
271201300031C-7-0-1
|
|
NIMH, NICHD, AND NINDS BRAIN AND TISSUE REPOSITORY
|
HAROUTUNIAN, VAHRAM
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
NY
|
$169,681
|
|
Human Fetal Tissue
|
2017
|
NIMH
|
271201300030C-6-0-1
|
|
Brain Bank
|
WOO, TSUNG-UNG W.
|
MCLEAN HOSPITAL
|
MA
|
$922,784
|
|
Human Fetal Tissue
|
2017
|
NINDS
|
271201300030C-6-0-1
|
|
Brain Bank
|
WOO, TSUNG-UNG W.
|
MCLEAN HOSPITAL
|
MA
|
$621,877
|
|
Human Fetal Tissue
|
2017
|
NIDDK
|
1ZIADK052034-11
|
|
What determines the location of meiotic crossovers in the mammalian genome?
|
CAMERINI-OTERO, RAFAEL
|
NIH
|
|
$1,544,128
|
|
Human Fetal Tissue
|
2017
|
NEI
|
1ZIAEY000419-14
|
|
Human Retinal Pigment Epithelial Physiology
|
MILLER, SHELDON
|
NIH
|
|
$1,289,029
|
|
Human Fetal Tissue
|
2017
|
NEI
|
1ZIAEY000481-09
|
|
The treatment of uveitic cystoid macular edema with topical Interferon gamma
|
MILLER, SHELDON
|
NIH
|
|
$99,762
|
|
Human Fetal Tissue
|
2017
|
NEI
|
1ZIAEY000450-10
|
|
Genetic and epigenetic regulation of retinal development and aging
|
SWAROOP, ANAND
|
NIH
|
|
$4,226,755
|
|
Human Fetal Tissue
|
2017
|
NCI
|
1ZIABC011423-06
|
|
Epigenetic studies in rhabdomyosarcoma
|
BARR, FREDERIC
|
NIH
|
|
$457,096
|
|
Human Fetal Tissue
|
2017
|
NCI
|
1ZIABC011427-06
|
|
Immunohistochemical analysis of tumors
|
BARR, FREDERIC
|
NIH
|
|
$1,745,892
|
|
Human Fetal Tissue
|
2017
|
NINDS
|
1ZIANS003130-07
|
|
Neuropathogenesis of Retroviral Infections
|
NATH, AVINDRA
|
NIH
|
|
$5,206,475
|
|
Human Fetal Tissue
|
2017
|
NIAID
|
1ZIAAI001141-07
|
|
HIV Infection in Humanized Mice
|
HASENKRUG, KIM
|
NIH
|
|
$554,798
|
|
Human Fetal Tissue
|
2017
|
NHGRI
|
1ZIAHG000215-15
|
|
Human Biochemical Genetics
|
GAHL, WILLIAM
|
NIH
|
|
$4,692,970
|
